Surrozen, Inc.

NASDAQ:SRZN

8.01 (USD) • At close September 18, 2024
Bedrijfsnaam Surrozen, Inc.
Symbool SRZN
Munteenheid USD
Prijs 8.01
Beurswaarde 25,678,859
Dividendpercentage 0%
52-weken bereik 4.5 - 16.19
Industrie Biotechnology
Sector Healthcare
CEO Mr. Craig C. Parker M.B.A.
Website https://www.surrozen.com

An error occurred while fetching data.

Over Surrozen, Inc.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its

Vergelijkbare Aandelen

Celcuity Inc. logo

Celcuity Inc.

CELC

15.01 USD

MyMD Pharmaceuticals, Inc. logo

MyMD Pharmaceuticals, Inc.

MYMD

1.81 USD

Equillium, Inc. logo

Equillium, Inc.

EQ

0.85 USD

Fortress Biotech, Inc. logo

Fortress Biotech, Inc.

FBIO

1.92 USD

Daré Bioscience, Inc. logo

Daré Bioscience, Inc.

DARE

3.23 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)